Assistance Publique des Hôpitaux de Paris SA
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1849-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.aphp.fr
Clearance of Asymptomatic Pharyngeal Carriage of Neisseria Gonorrhoeae With or Without Ceftriaxone Treatment: Randomized Non-inferiority Study
Phase 3
Not yet recruiting
- Conditions
- Neisseria Gonorrhoeae InfectionAsymptomatic Pharyngeal Carriage
- Interventions
- Other: Absence of antibiotic treatmentDrug: Ceftriaxone
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 254
- Registration Number
- NCT05971550
Clonal Hematopoiesis of Immunological Significance
Not yet recruiting
- Conditions
- Hematopoiesis ClonalHematologic DiseasesLeukemia Myelomonocytic ChronicMyelodysplastic SyndromesAutoinflammatory DiseasesClonal Hematopoiesis of Indeterminate PotentialMonoclonal Gammopathy of Undetermined SignificanceAutoimmune DiseasesMyeloproliferative DisordersImmune System Diseases
- Interventions
- Other: observational cohort study
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2023-08-23
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 1000
- Registration Number
- NCT05969821
Improving Care Pathway Using Simplified Digital Tools for Oncology Patients: a Multicenter "Before-and-after" Study
Not yet recruiting
- Conditions
- Numeric ApplicationCompliance, TreatmentOncologyAdverse EventCare TelemonitoringPatient Reported Outcome (PRO)
- Interventions
- Other: Nouveal numeric application "Onco'nect"
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 480
- Registration Number
- NCT05968027
Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell Transplantation
Not yet recruiting
- Conditions
- Systemic SclerosisSARS-CoV 2 Vaccination
- First Posted Date
- 2023-07-25
- Last Posted Date
- 2023-07-25
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 72
- Registration Number
- NCT05960058
Circulating Tumor DNA Study in Patients With Endometrial Cancer
Recruiting
- Conditions
- Endometrial Cancer
- Interventions
- Other: Whole blood
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 130
- Registration Number
- NCT05955079
- Locations
- 🇫🇷
Hôpital Cochin, Paris, France
Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis
Not Applicable
Not yet recruiting
- Conditions
- Cardiac Sarcoidosis
- Interventions
- Diagnostic Test: PET/MRI
- First Posted Date
- 2023-07-20
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 180
- Registration Number
- NCT05954507
Prediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population
Recruiting
- Conditions
- Anesthesia, LocalAnesthesia
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 396
- Registration Number
- NCT05951764
- Locations
- 🇫🇷
AP-HP, Lariboisière Hospital, Department of Anesthesiology and Intensive Care, Paris, France
Treatment Resistant Depression and Vagus Nerve Stimulation
Not Applicable
Not yet recruiting
- Conditions
- Treatment Resistant Depression (TRD)
- Interventions
- Device: Vagus Nerve Stimulation (VNS)Other: Best Medical Treatment
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 166
- Registration Number
- NCT05952674
Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.
Early Phase 1
Recruiting
- Conditions
- COVID-19
- Interventions
- Procedure: Lymph node aspiration / Blood sampling
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 12
- Registration Number
- NCT05951920
- Locations
- 🇫🇷
GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur, Paris, France
Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.
Not yet recruiting
- Conditions
- Neuropathic Pain
- First Posted Date
- 2023-07-18
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 50
- Registration Number
- NCT05949554
© Copyright 2025. All Rights Reserved by MedPath